CZEN-001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCZEN-001
Drug Alias NameCZEN-001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZengen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZengen
Active IndicationsN/A
Inactive IndicationsPruritus

Other Information

ATC CodeN/A
Related LinksN/A